# MapLight Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jul 31, 2026

- Company: [MapLight Therapeutics, Inc.](/companies/mplt.md) (CIK 1770069)
- Form: SCHEDULE 13D/A
- Filed: 2026-07-31
- Accepted by EDGAR: Jul 31, 2026, 13:25 ET
- Period: not reported
- Accession: 0001388325-26-000034
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jul 31, 2026.
Source: SEC EDGAR, the filing index for accession 0001388325-26-000034. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
